PMV Pharmaceuticals (PMVP) Prepaid Assets (2019 - 2026)
PMV Pharmaceuticals' (PMVP) quarterly Prepaid Assets came in at $2.2 million in Q1 2026, down 28.29% YoY from $3.1 million in Q1 2025, and down 2.32% on a QoQ basis from $2.3 million in Q4 2025.
PMV Pharmaceuticals (PMVP) Prepaid Assets (2019 - 2026) Analysis & Trends
PMV Pharmaceuticals (PMVP) has 8 years of Prepaid Assets data on file, last reported at $2.2 million in Q1 2026.
- Quarterly Prepaid Assets fell 28.29% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (down 28.29% YoY) and the FY2025 annual result came in at $2.3 million, down 63.19% from the prior year.
- Prepaid Assets retreated to $2.2 million in Q1 2026, from $2.3 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $6.2 million in Q4 2024 to a low of $2.2 million in Q1 2026.
- A 5-year average of $3.8 million and a median of $3.5 million in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets surged 133.06% — and 2025, when it sank 63.19%.
- Tracing PMVP's Prepaid Assets over 5 years: stood at $5.1 million in 2022, then plunged by 31.19% to $3.5 million in 2023, then surged by 75.75% to $6.2 million in 2024, then slumped by 63.19% to $2.3 million in 2025, then decreased by 2.32% to $2.2 million in 2026.
- The last three Prepaid Assets figures came in at $2.2 million (Q1 2026), $2.3 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | PMV Pharmaceuticals | 70.74 Mn | -8.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.23 Mn |
| Dec 31, 2025 | 2.28 Mn |
| Sep 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | 3.04 Mn |
| Mar 31, 2025 | 3.11 Mn |
| Dec 31, 2024 | 6.20 Mn |
| Sep 30, 2024 | 5.96 Mn |
| Jun 30, 2024 | 5.05 Mn |
| Mar 31, 2024 | 3.70 Mn |
| Dec 31, 2023 | 3.53 Mn |
| Sep 30, 2023 | 2.56 Mn |
| Jun 30, 2023 | 2.50 Mn |
| Mar 31, 2023 | 3.02 Mn |
| Dec 31, 2022 | 5.13 Mn |
| Sep 30, 2022 | 5.50 Mn |
| Jun 30, 2022 | 3.61 Mn |
| Mar 31, 2022 | 4.23 Mn |
| Dec 31, 2021 | 3.30 Mn |
| Sep 30, 2021 | 5.08 Mn |
| Jun 30, 2021 | 3.91 Mn |